Life Technologies (LIFE, $47.11, Buy, PT $60, Mkt Cap $8.6B) - Jon Wood
-With ~80% of composite revenue attributable to higher-margined recurring consumables and service revenue streams, LIFE’s defensive business mix characteristics are a compelling investment merit in current market conditions, in our view. Additionally, we believe LIFE is capable of growing organic revenues at a 1% to 2% premium to its end-markets annually over the intermediate-term, owing to its entrenched presence in higher-growth life science product niches, superior pricing power, elevated new product vitality and ongoing synergies from the ABI merger
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.